Skip to content
Research Article Open access CC BY 4.0

Psychimmunological Aspects and Quality of Life in Patients with Irritable Bowel Syndrome

Ibrahim Mohamed El-Mrasey, Gamal Taha Shamaa, Mai Abd EL-Raouf Issa, Mohamed Zakaria Hussein, Ahmed Fawzy Selim

International Neuropsychiatric Disease Journal · pp. 101–111 · Published 6 Oct 2023

10.9734/indj/2023/v20i3404

Abstract

Background: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder and may coexist with psychiatric disorders. We aimed to establish new directions for diagnosis of psychiatric disorders in IBS patients by assessment of the quality of life (QOL) and the immunological role in IBS. Methods: This study was carried out on 80 subjects aged from 18 to 65 years old, both sexes, assigned into two groups: group I included 60 patients were diagnosed with IBS according to ROM-IV diagnostic criteria and were further divided according to age into two groups, first group is (18-40) years and second group is (41-65) years. Group II: Included 20 subjects as a healthy Control group. Results: The younger age group of patients with IBS have a significantly better overall QOL and its domains than the older age group. Hamilton Rating Scale of Depression scores were significantly higher in female patients and older age groups. Patients with psychiatric comorbidity had a lower QOL and its domains than patients without psychiatric comorbidity with a significant difference between both groups. There was a significant difference in serum Interlukin-6 between patients with IBS and healthy control group. Also in serum Interlukin-6 patients with IBS comorbid psychiatric disorders and patients without psychiatric comorbidity with. Conclusions: Psychiatric symptoms are presented earlier in Egyptian IBS. A higher percentage of psychiatric disorders are presented with severe forms of IBS affecting the prognosis of IBS and subsequently the QOL and health costs.

Psych immunological aspects irritable bowel syndrome quality of life

References (41)

  1. 1 A RATING SCALE FOR DEPRESSION [DOI]
  2. 2 Functional Bowel Disorders [DOI]
  3. 3 Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV [DOI]
  4. 4 Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis [DOI]
  5. 5 The impact of irritable bowel syndrome on health-related quality of life [DOI]
  6. 6 Quality of Life in Persons with Irritable Bowel Syndrome (Development and Validation of a New Measure) [DOI]
  7. 7 The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II).
  8. 8 Immune Activation in Patients With Irritable Bowel Syndrome [DOI]
  9. 9 Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis [DOI]
  10. 10 Enzyme immunoassay techniques an overview [DOI]
  11. 11 The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis [DOI]
  12. 12 Montreal Cognitive Assessment Arabic version: Reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo [DOI]
  13. 13 Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice [DOI]
  14. 14 AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review [DOI]
  15. 15 The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations [DOI]
  16. 16 Psychosocial determinants of irritable bowel syndrome [DOI]
  17. 17 Anxiety, Depression and Quality of Life in Patients with Irritable Bowel Syndrome [DOI]
  18. 18 Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? [DOI]
  19. 19 Comorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A Review [DOI]
  20. 20 Irritable bowel syndrome: Relations with functional, mental, and somatoform disorders [DOI]
  21. 21 Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women [DOI]
  22. 22 Depression Preceding Diagnosis of Bipolar Disorder [DOI]
  23. 23 Anxiety and Depression in Irritable Bowel Syndrome [DOI]
  24. 24 Psychiatric, Somatic and Other Functional Gastrointestinal Disorders in Patients With Irritable Bowel Syndrome at a Tertiary Care Center [DOI]
  25. 25 Irritable bowel syndrome, anxiety, depression and personality characteristics.
  26. 26 Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16–50years [DOI]
  27. 27 Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea [DOI]
  28. 28 Depressive symptoms in patients with irritable bowel syndrome: a meta-analysis of comparative studies [DOI]
  29. 29 Quality of life in persons with irritable bowel syndrome : Development and validation of a new measure.
  30. 30 Is there a causal link between psychological disorders and functional gastrointestinal disorders? [DOI]
  31. 31 Psychiatric Co-morbidity in Patients With Irritable Bowel Syndrome at a Tertiary Care Center in Northern India [DOI]
  32. 32 Anxiety-depressive disorders among irritable bowel syndrome patients in Guilan, Iran [DOI]
  33. 33 Subthreshold Psychiatric Psychopathology in Functional Gastrointestinal Disorders: Can It Be the Bridge between Gastroenterology and Psychiatry? [DOI]
  34. 34 Irritable Bowel Syndrome: assessment of prevalence and risk factors in Saudi University students using Rome IV Criteria [DOI]
  35. 35 Neuroendocrine markers and psychological features in patients with irritable bowel syndrome [DOI]
  36. 36 Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome [DOI]
  37. 37 Immune Activation in Patients With Irritable Bowel Syndrome [DOI]
  38. 38 Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice [DOI]
  39. 39 Irritable Brain Caused by Irritable Bowel? A Nationwide Analysis for Irritable Bowel Syndrome and Risk of Bipolar Disorder [DOI]
  40. 40 Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation [DOI]
  41. 41 A study of psychiatric comorbidities in irritable bowel syndrome [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

2

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.